United States Vaccines Market 2015 - 2025: Top 21 Vaccines Analysis, Deal Trends, Players and Forecasts

November 2018 | 115 pages | ID: U5E9590A03DEN
DPI Research

Abstracts

United States vaccines market is set to surpass US$ 21 Billion threshold by 2025.

“United States Vaccines Market 2015 - 2025: Top 21 Vaccines Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the United States vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for United States vaccines market. The report includes historic data from 2015 to 2017 and forecasts until 2025.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025.The report provides clear insight into current and future developments of the United States vaccines market. The report also explores detailed analysis of top 21 vaccines market assessment in United States from 2015 to 2017 and forecasts to 2025. The report also details the latest information about the vaccines pricing trends and regulatory landscape in United States.

Additionally, the report includes assessment of promising vaccines in the clinical development by major companies. Key trends in terms of collaboration, merger & acquisition, distribution, exclusive and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States vaccines market.

The report concludes with the profiles of major players in the United States vaccines market. The key market players are evaluated on various parameters such as business overview, promising vaccines in the clinical development and recent development.

The major companies dominating this market for its products, services and continuous product developments are:

Pfizer, Merck, Sanofi Pasteur and GlaxoSmithKline(GSK)

Top 21 Vaccines Covered Under This Report Are:

• Prevnar/Prevnar 13
• Gardasil/Gardasil 9
• Fluzone
• Varivax
• Menactra
• Proquad
• Pneumovax
• FluLaval/Fluarix
• Havrix/Twinrix/Engerix-B
• MMR II
• Adacel
• Boostrix
• Bexsero
• Menveo
• Trumenba
• Shingrix
• Pentacel
• Recombivax HB
• Rotateq
• Rotarix
• Pediarix/Infanrix

The Latest Industry Data Included in this Report:

• United States Vaccines Market Size & Analysis (2015 - 2025)
• United States Vaccines Market Share & Y-o-Y Growth (%), 2015 – 2025
• United States Top 21 Vaccines Market Assessment & Opportunity (2015 – 2025)
• United States Vaccines Pricing Trends & Analysis
• United States Vaccines Regulatory System
• Major Deals in United States Vaccines Market
• Promising Vaccines in Clinical Development by Major Companies
• Key Market Drivers and Inhibitors of the United States Vaccines Market
• Major Companies Analysis

The answers to the following key questions can be found in the report:

• What is the size of the United States vaccines market during 2015 -2025?
• What will be the revenue generated by each vaccine during the forecast period?
• Which major vaccine provides highest market share?
• How are the overall market and vaccine type growing?
• What are the key drivers and inhibitors in the current market? What will be the impact of drivers and inhibitors in the future?
• What are the various vaccines available in the United States?
• How is the market predicted to develop in the future?
• Who are the key players in this market space?

Contents

1. EXECUTIVESUMMARY

2. UNITED STATES VACCINES MARKET SIZE & ANALYSIS (2015 - 2025)

3. UNITED STATES VACCINES MARKET SHARE & Y-O-Y GROWTH (%), 2015 – 2025

4. KEY DRIVERS AND INHIBITORS OF THE UNITED STATES VACCINES MARKET

4.1 Market Drivers
4.2 Market Inhibitors

5. UNITED STATES TOP 21 VACCINES MARKET ASSESSMENT & OPPORTUNITY (VALUE),2015 – 2025

5.1 Prevnar/Prevnar
5.2 Gardasil/Gardasil
5.3 Fluzone
5.4 Varivax
5.5 Menactra
5.6 Proquad
5.7 Pneumovax
5.8 Fluarix/FluLaval
5.9 Havrix/Twinrix/Engerix-B
5.10 M-M-R II
5.11 Adacel
5.12 Boostrix
5.13 Bexsero
5.14 Menveo
5.15 Trumenba
5.16 Shingrix
5.17 Pentacel
5.18 Recombivax HB
5.19 Rotateq
5.20 Rotarix
5.21 Pediarix/Infanrix
5.22 Other Vaccines

6. UNITED STATES VACCINES PRICING TRENDS & ANALYSIS

7. UNITED STATES VACCINES REGULATORY SYSTEM

8. MAJOR DEALS IN UNITED STATES VACCINES MARKET

8.1 Merger & Acquisitions
8.2 Collaboration Deal
8.3 Licensing Agreement
8.4 Exclusive Agreement
8.5 Distribution Agreement

9. KEY COMPANIES ANALYSIS

9.1 Sanofi Pasteur
  9.1.1 Business Overview
  9.1.2 Promising Vaccines in Clinical Development
  9.1.3 Recent Development
9.2 GlaxoSmithKline (GSK)
  9.2.1 Business Overview
  9.2.2 Promising Vaccines in Clinical Development
  9.2.3 Recent Development
9.3 Merck
  9.3.1 Business Overview
  9.3.2 Promising Vaccines in Clinical Development
  9.3.3 Recent Development
9.4 Pfizer
  9.4.1 Business Overview
  9.4.2 Promising Vaccines in Clinical Development
  9.4.3 Recent Development

List Of Tables

LIST OF TABLES

Table 3–1: United States Vaccines Market Share & Y-o-Y Growth (Percent), 2015 - 2017
Table 3–2: United States Vaccines Market Share & Y-o-Y Growth Forecast (Percent), 2018 - 2025
Table 6–1: United States Adult Vaccines Price, 2018 – 2019
Table 6–2: United States Adult Influenza Vaccines Price, 2018 – 2019
Table 6–3: United States Pediatric Vaccines Price, 2018 – 2019
Table 6–4: United States Pediatric Influenza Vaccines Price, 2018 – 2019
Table 7–1: United States Simplified Regulatory Pathway from Preclinical to the Marketing Authorization
Table 8–1: Merger & Acquisitions in Vaccines Market (Million US$),2003 – 2017
Table 8–2: Collaboration Deal in Vaccines Market,2007 – 2018
Table 8–3: Licensing Agreement in Vaccines Market,2007 – 2018
Table 8–4: Exclusive Agreement in Vaccines Market,2009 – 2016
Table 8–5: Distribution Agreement in Vaccines Market,2005 – 2016
Table 9–1: Sanofi Promising Vaccines in Clinical Development
Table 9–2: GSK Promising Vaccines in Clinical Development
Table 9–3: Merck Promising Vaccines in Clinical Development
Table 9–4: Pfizer Promising Vaccines in Clinical Development

List Of Figures

LIST OF FIGURES

Figure 2–1: United States Vaccines Market Size (Million US$),2015 - 2017
Figure 2–2: United States Vaccines Market Size Forecast (Million US$),2018 - 2025
Figure 5–1: United States Prevnar/Prevnar 13 Market Value (Million US$),2015 - 2017
Figure 5–2: United States Prevnar/Prevnar 13 Market Value Forecast (Million US$),2018-2025
Figure 5–3: United States Gardasil/Gardasil 9 Market Value (Million US$),2015 - 2017
Figure 5–4: United States Gardasil/Gardasil 9 Market Value Forecast (Million US$),2018 - 2025
Figure 5–5: United States Fluzone Market Value (Million US$),2015 - 2017
Figure 5–6: United States Fluzone Market Value Forecast (Million US$),2018 - 2025
Figure 5–7: United States Varivax Market Value (Million US$),2015 - 2017
Figure 5–8: United States Varivax Market Value Forecast (Million US$),2018 - 2025
Figure 5–9: United States Menactra Market Value (Million US$),2015 - 2017
Figure 5–10: United States Menactra Market Value Forecast (Million US$),2018 - 2025
Figure 5–11: United States Proquad Market Value (Million US$),2015 - 2017
Figure 5–12: United States Proquad Market Value Forecast (Million US$),2018 – 2025
Figure 5–13: United States Pneumovax 23 Market Value (Million US$),2015 - 2017
Figure 5–14: United States Pneumovax 23 Market Value Forecast (Million US$),2018 - 2025
Figure 5–15: United States Fluarix/FluLaval Market Value (Million US$),2015 - 2017
Figure 5–16: United States Fluarix/FluLaval Market Value Forecast (Million US$),2018 - 2025
Figure 5–17: United States Havrix/Twinrix/Engerix-B Market Value (Million US$),2015 - 2017
Figure 5–18: United States Havrix/Twinrix/Engerix-B Market Value Forecast (Million US$),2018 - 2025
Figure 5–19: United States M-M-R ll Market Value (Million US$),2015 - 2017
Figure 5–20: United States M-M-R ll Market Value Forecast (Million US$),2018 - 2025
Figure 5–21: United States Adacel Market Value (Million US$),2015 - 2017
Figure 5–22: United States Adacel Market Value Forecast (Million US$),2018 - 2025
Figure 5–23: United States Boostrix Market Value (Million US$),2015 - 2017
Figure 5–24: United States Boostrix Market Value Forecast (Million US$),2018 - 2025
Figure 5–25: United States Bexsero Market Value (Million US$),2015 - 2017
Figure 5–26: United States Bexsero Market Value Forecast (Million US$),2018 - 2025
Figure 5–27: United States Menveo Market Value (Million US$),2015 - 2017
Figure 5–28: United States Menveo Market Value Forecast (Million US$),2018 - 2025
Figure 5–29: United States Trumenba Market Value (Million US$),2015 - 2017
Figure 5–30: United States Trumenba Market Value Forecast (Million US$),2018 - 2025
Figure 5–31: United States Shingrix Market Value & Forecast (Million US$),2017 - 2025
Figure 5–32: United States Pentacel Market Value (Million US$),2015 - 2017
Figure 5–33: United States Pentacel Market Value Forecast (Million US$),2018 – 2025
Figure 5–34: United States Recombivax HB Market Value (Million US$),2015 – 2017
Figure 5–35: United States Recombivax HB Market Value Forecast (Million US$),2018 – 2025
Figure 5–36: United States Rotateq Market Value (Million US$),2015 – 2017
Figure 5–37: United States Rotateq Market Value Forecast (Million US$),2018 – 2025
Figure 5–38: United States Rotarix Market Value (Million US$),2015 – 2017
Figure 5–39: United States Rotarix Market Value Forecast (Million US$),2018 – 2025
Figure 5–40: United States Pediarix/Infanrix Market Value (Million US$),2015 – 2017
Figure 5–41: United States Pediarix/Infanrix Market Value Forecast (Million US$),2018 – 2025
Figure 5–42: United States Other Vaccines Market Value (Million US$),2015 – 2017
Figure 5–43: United States Other Vaccines Market Value Forecast (Million US$),2018 – 2025